Australia markets closed

OncoCyte Corporation (OCX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.7400+0.0900 (+3.40%)
At close: 04:00PM EDT
2.7800 +0.04 (+1.46%)
After hours: 04:19PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close2.6500
Open2.7500
Bid0.0000 x 0
Ask0.0000 x 0
Day's range2.7200 - 2.9500
52-week range2.0800 - 4.8600
Volume40,524
Avg. volume62,501
Market cap36.619M
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Favorable Oncocyte VitaGraft Kidney Study Results Published in the New England Journal of Medicine

    Late-breaking presentation of data at American Transplant Congress on Monday, June 3Data show potential to monitor for therapeutic efficacy and recurrencePotential repeat testing opportunities with claims expansionIRVINE, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, today announced that favorable data regarding its lead product VitaGraft™ Kidney was published in the New England Journal of Medicine. Oncocyte’s Drs. Ekke Schuetz and

  • GlobeNewswire

    Oncocyte Reports First Quarter 2024 Financial Results

    Conference Call on Wednesday, May 15, 2024 at 1:30 p.m. PT / 4:30 p.m. ETIRVINE, Calif., May 15, 2024 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, today reported financial results for the quarter ended March 31, 2024. Recent Highlights Announced global commercialization partnership with Bio-Rad Laboratories, Inc.On track to ship research use only (RUO) GraftAssure™ transplant monitoring test kits to initial customers in Asia, the U.S., and the EU in 2Q

  • GlobeNewswire

    Oncocyte to Announce First Quarter 2024 Financial Results

    Conference Call and Webcast on Wednesday, May 15, 2024 at 1:30 p.m. PT / 4:30 p.m. ETIRVINE, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, announced today that the company will release its first quarter 2024 financial results on Wednesday, May 15, 2024, after U.S. market close. The company will host a conference call and webcast on Wednesday, May 15, 2024, at 4:30 p.m. Eastern Time to discuss its financial results and highlights. In